BIGBEAR
PHARMACEUTICAL
Alpelisib is an oral phosphatidylinositol-3-kinase (PI3K) inhibitor. Its mechanism of action is to block the activity of PI3K enzymes, inhibit the proliferation and spread of tumor cells, and simultaneously induce the apoptosis of breast cancer cells.
AuthenticGuaranteeFast DeliveryPrivacy Alpelisib is typically used in combination with fulvestrant. The focus on special populations in this text covers only the Alpelisib component, includ···【More】
Update: 22 Sep,2026Source: BigbearViews: 160
Before starting Alpelisib treatment, please inform your doctor in a timely manner about all medications you are currently taking to minimize potential···【More】
Update: 22 Sep,2026Source: BigbearViews: 154
During treatment, if adverse reactions such as rash, hyperglycemia, diarrhea or colitis, or other toxicities occur, the dosage should be adjusted acco···【More】
Update: 20 Sep,2026Source: BigbearViews: 159
Mechanism of Action of Alpelisib1. Selective inhibition of the phosphatidylinositol-3-kinase alpha isoform (PI3Kα). Mutations in the gene encoding PI3···【More】
Update: 31 Jul,2026Source: BigbearViews: 174
Alpelisib Specific Drug Interactions1. Bisphosphonates (e.g., alendronate, ibandronate, risedronate, zoledronic acid): May increase the risk of osteon···【More】
Update: 31 Jul,2026Source: BigbearViews: 154
Alpelisib Special Considerations for Specific Populations1. PregnancyMay cause fetal harm.2. LactationIt is unknown whether alpelisib is excreted into···【More】
Update: 31 Jul,2026Source: BigbearViews: 167
Alpelisib is an antineoplastic agent that selectively inhibits the phosphatidylinositol 3-kinase alpha isoform (PI3Kα).Alpelisib ContraindicationsHist···【More】
Update: 31 Jul,2026Source: BigbearViews: 146
Alpelisib may cause various side effects during treatment. If you do not know much about the side effects of alpelisib, please consult your doctor pro···【More】
Update: 30 Jul,2026Source: BigbearViews: 181
Alpelisib ContraindicationsHypersensitivity to the active substance or to any of the excipients is contraindicated.Alpelisib Age Restrictions1. Breast···【More】
Update: 29 Jul,2026Source: BigbearViews: 156
Dose Adjustments for Adverse Reactions in the Treatment of PIK3CA-Related Overgrowth Spectrum1. Recommended Dose Reduction in Adult Patients(1) First ···【More】
Update: 29 Jul,2026Source: BigbearViews: 175
Alpelisib Dose Adjustments in Special Populations1. Renal Impairment Adjustments(1) Mild to moderate renal impairment: No dose adjustment required.(2)···【More】
Update: 29 Jul,2026Source: BigbearViews: 158
Alpelisib dosage and administration depend on the disease being treated and the patient's age; specific use should be consulted with a physician. ···【More】
Update: 29 Jul,2026Source: BigbearViews: 153
Alpelisib was approved by the U.S. Food and Drug Administration (FDA) in 2019 for use in combination with fulvestrant to treat hormone receptor-positi···【More】
Update: 23 Mar,2026Source: BigbearViews: 209
Alpelisib has been approved for marketing in several countries and regions, including the United States, the European Union, and Japan, but it has not···【More】
Update: 23 Mar,2026Source: BigbearViews: 229
Alpelisib, an oral small-molecule PI3Kα inhibitor from Novartis, Switzerland, offers new hope for patients with advanced or metastatic breast cancer c···【More】
Update: 23 Mar,2026Source: BigbearViews: 211
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos
